Clinical trial
Feeding the Critically Ill During Phases of Altered Redox Status (FEDOX): a Prospective Randomized Trial
NCT03085615 is registered in ClinicalTrials.gov with University of Illinois at Chicago as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- Feeding the Critically Ill During Phases of Altered Redox Status (FEDOX): a Prospective Randomized Trial
- Lead sponsor
- University of Illinois at Chicago
- Phase
- Not applicable
- Overall status
- Completed
- Start date
- March 15, 2017
- Completion date
- October 13, 2018
- Enrollment
- 35 (actual)
- Sites
- 1
Conditions
As the registry lists them; a condition with its own page is linked.
acute respiratory distress syndrome, euthyroid sick syndromes, oxidative stress, systemic inflammatory response syndrome